Determination of Loratadine in Human Plasma by HPLC with Fluorescence Detector and Study on Its Bioavailability.

Xiao-jie Xu,Er-xin Shang,Fu-rong Qiu,Guo-guang Mao,Bing-ren Xiang
DOI: https://doi.org/10.3321/j.issn:0513-4870.2004.02.011
2004-01-01
Abstract:Aim To establish an HPLC-fluorescence method for determination of loratadine in human plasma and evaluate its relative bioavailability. Methods An Alltech-C18 column and a mobile phase of acetonitrile-water-glacial acetic acid-triethylamine (90∶100∶6∶0.15) were used. The fluorescence detector was set at Ex 274 nm, Em 450 nm. The flow rate was 1 mL·min-1. Results The calibration curve was linear over a concentration range of 0.2-30 μg·L-1. The limit of quantification was 0.2 μg·L-1. The average method recoveries varied from 96% to 98%. The results showed AUC, Tmax, Cmax and T1/2β between the testing tablets, testing capsules and reference tablets had no significant difference (P>0.05). Relative bioavailabilities were 107%±17% and 100%±14% respectively. Conclusion The three formulations were bioequivalent.
What problem does this paper attempt to address?